Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
OCUL
#1780
Ocular Therapeutix, Inc.
8.940
0
-3.14%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-3.14%
Monatliche Änderung
-17.45%
6 month change
-22.26%
Jahresänderung
-22.26%
Vorheriger Schlusskurs
9.230
0
Open
8.940
0
Bid
Ask
Low
8.940
0
High
8.940
0
Volumen
212
Märkte
Aktien
Gesundheitswesen
OCUL
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
76.07 M
76.75 M
77.51 M
148.63 M
159.02 M
217.69 M
—
Valuation ratios
Enterprise value
1.35 B
370.81 M
113.95 M
519.09 M
965.95 M
1.91 B
6.09 B
Price to earnings ratio
—
-7.11
-2.88
-4.72
-7
-8.55
-30.99
Price to sales ratio
—
13.16
4.48
7.04
21.21
43.75
124.69
Price to cash flow ratio
—
-8.74
-3.87
-5.86
-10.04
-11.09
-38.15
Price to book ratio
—
6.51
6.52
4.52
4.29
3.47
7.28
Enterprise value to EBITDA ratio
-22.42
38.39
7.27
14.62
34.18
-125.77
-175.56
Profitability ratios
Return on assets %
0.59
0.03
0.48
0.32
0.42
0.33
0.56
Return on equity %
2.05
0.07
2.01
0.89
0.61
0.41
0.83
Return on invested capital %
1 116.11
1 509.38
1 662.57
1 463.43
2 762.97
3 907.27
—
Gross margin %
88.03
89.88
91.18
90.96
91.17
87.35
349.53
Operating margin %
361.13
179.3
152.74
140.96
269.57
519.75
2 098.88
EBITDA margin %
-345.19
22.19
30.44
60.77
44.35
-29.17
-1 583.58
Net margin %
894.31
15.06
137.95
138.14
303.67
511.9
2 067.85
Liquidity ratios
Quick ratio
9.19
7.22
4.07
6.59
10.59
15.32
43.26
Current ratio
9.23
7.26
4.13
6.66
10.66
15.39
43.56
Inventory turnover
1.93
3.6
2.82
2.47
2.11
1.99
2.01
Asset turnover
0.1
0.19
0.29
0.29
0.18
0.08
0.11
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.16
0.25
0.36
0.3
0.15
0.09
0.59
Long term debt to total equity ratio
0.54
0.58
1.53
0.82
0.22
0.11
0.87
Per share metrics
Operating cash flow per share
—
0.8
0.72
0.82
0.85
1.09
1.15
EBIT per share
—
0.09
0.16
0.38
0.15
-0.1
-1.14
EBITDA per share
—
0.12
0.19
0.41
0.18
-0.08
-1.12
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
2
1.24
2.29
2.48
3.94
10.14
Net current asset value per share
—
2.33
1.57
2.71
2.79
4.18
11.08
Tangible book value per share
—
1.07
0.43
1.06
1.99
3.49
8.24
Working capital per share
—
2.01
1.19
2.31
2.53
3.91
10.07
Book value per share
—
1.07
0.43
1.06
1.99
3.49
8.24
Nachrichten
Ocular Therapeutix: CSO veräußert Aktien im Wert von 25.000 $
Ocular Therapeutix: Entwicklungsvorstand verkauft Aktien im Wert von 23.000 US-Dollar
Ocular Therapeutix CSO Heier sells $25k in stock
Ocular Therapeutix chief development officer Kaiser sells $23k in stock
CEO von Ocular Therapeutix verkauft Aktien im Wert von 166.000 US-Dollar
Ocular Therapeutix CEO Dugel sells $166k in stock
Waheed Nadia, Ocular Therapeutix CMO, sells $27k in stock
Needham senkt Kursziel für Ocular Therapeutix nach Studienergebnissen
Ocular Therapeutix: Strategiechef Nayak verkauft Aktien im Wert von 93.000 $
Apple, General Electric among market cap stock movers on Tuesday
Guggenheim bestätigt Kaufempfehlung für EyePoint nach positiven Studiendaten eines Konkurrenten
AMD, Micron Tech among market cap stock movers on Tuesday